Physician profile
Andrew Lin
NPI 1295396364
$4,198.52
in general payments reported to CMS, 2019-2025
11 companies · $3,014 in 2025
The $3,014 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.37 · 2022: $23.11 · 2023: $227 · 2024: $915 · 2025: $3,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,221 · Education: $1,000 · Food and Beverage: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,221.21 |
| Education | $1,000.00 |
| Food and Beverage | $934.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,301.22 | 2024-2025 | |
| Medtronic, INC. | $230.22 | 2021-2025 | Azure Xt Dr Mri Surescan |
| Phathom Pharmaceuticals, INC. | $175.81 | 2025 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Breztri |
| Vertex Pharmaceuticals Incorporated | $124.97 | 2025 | |
| Olympus America INC. | $85.38 | 2023 | 4k Cable 8.5m |
| Paratek Pharmaceuticals, INC. | $49.36 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $34.37 | 2024-2025 | Stravix, Grafix Pl, Versajet |
| Gilead Sciences, INC. | $31.75 | 2025 | |
| Baxter Healthcare | $23.11 | 2022 | |
| Integra Lifesciences Corporation | $17.33 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.